Novo’s unit closure leads to 133 lay-offs
Novo Nordisk’s decision to close the business unit for inflammatory diseases will lead to significantly fewer lay-offs than initially thought.
BY STEFAN SINGH KAILAY
133. That is how many jobs will be lost due to Novo Nordisk’s decision to close down all activities within its inflammatory diseases unit, as communicated by the company on September 2nd.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Krogsgaard: The alternative would be a major acquisition
For abonnenter
Novo considers gene therapy
For abonnenter
